{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:37Z","timestamp":1772119537009,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ck0106333"],"award-info":[{"award-number":["JP19ck0106333"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ck0106610"],"award-info":[{"award-number":["JP20ck0106610"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10147-024-02608-x","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T16:15:36Z","timestamp":1724429736000},"page":"1746-1755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-0159","authenticated-orcid":false,"given":"Hajime","family":"Hosoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Sakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotone","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ichi","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minori","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masazumi","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ichi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Suita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"2608_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00043426-200105000-00008","volume":"23","author":"RB Raney","year":"2001","unstructured":"Raney RB, Anderson JR, Barr FG et al (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23:215\u2013220","journal-title":"J Pediatr Hematol Oncol"},{"key":"2608_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.24118","volume":"59","author":"S Malempati","year":"2012","unstructured":"Malempati S, Hawkins DS (2012) Rhabdomyosarcoma: review of the Children\u2019s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer 59:5\u201310","journal-title":"Pediatr Blood Cancer"},{"key":"2608_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ped.12867","volume":"58","author":"H Hosoi","year":"2016","unstructured":"Hosoi H (2016) Current status of treatment for pediatric rhabdomyosarcoma in the USA and Japan. Pediatr Int 58:81\u201387","journal-title":"Pediatr Int"},{"key":"2608_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1200\/JCO.1987.5.1.46","volume":"5","author":"W Lawrence","year":"1987","unstructured":"Lawrence W, Gehan EA, Hays DM et al (1987) Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 5:46\u201354","journal-title":"J Clin Oncol"},{"key":"2608_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1165::AID-CNCR21>3.0.CO;2-5","volume":"80","author":"W Lawrence","year":"1997","unstructured":"Lawrence W, Anderson JR, Gehan EA et al (1997) Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children\u2019s Cancer Study Group. Pediatric Oncology Group. Cancer 80:1165\u20131170","journal-title":"Cancer"},{"key":"2608_CR6","first-page":"415","volume-title":"American Society of Clinical Oncology educational book","author":"CA Arndt","year":"2013","unstructured":"Arndt CA (2013) Risk stratification of rhabdomyosarcoma: a moving target. American Society of Clinical Oncology educational book. American Society of Clinical Oncology, Alexandria, pp 415\u2013419"},{"key":"2608_CR7","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1200\/JCO.2012.44.6476","volume":"31","author":"AR Weiss","year":"2013","unstructured":"Weiss AR, Lyden ER, Anderson JR et al (2013) Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children\u2019s Oncology Group Soft Tissue Sarcoma Committee. J Clin Oncol 31:3226\u20133232","journal-title":"J Clin Oncol"},{"key":"2608_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","volume":"13","author":"WM Crist","year":"1995","unstructured":"Crist WM, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610\u2013630","journal-title":"J Clin Oncol"},{"key":"2608_CR9","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","volume":"19","author":"WM Crist","year":"2001","unstructured":"Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091\u20133102","journal-title":"J Clin Oncol"},{"key":"2608_CR10","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1200\/JCO.2000.18.12.2427","volume":"18","author":"KS Baker","year":"2000","unstructured":"Baker KS, Anderson JR, Link MP et al (2000) Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18:2427\u20132434","journal-title":"J Clin Oncol"},{"key":"2608_CR11","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R","volume":"79","author":"JA Ortega","year":"1997","unstructured":"Ortega JA, Donaldson SS, Ivy SP et al (1997) Veno-occlusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Children\u2019s Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center. Cancer 79:2435\u20132439","journal-title":"Cancer"},{"key":"2608_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/1097-0142(20010201)91:3<613::AID-CNCR1042>3.0.CO;2-R","volume":"91","author":"LB Kenney","year":"2001","unstructured":"Kenney LB, Laufer MR, Grant FD et al (2001) High risk of infertility and long-term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 91:613\u2013621","journal-title":"Cancer"},{"key":"2608_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S1470-2045(14)70408-5","volume":"15","author":"DM Green","year":"2014","unstructured":"Green DM, Liu W, Kutteh WH et al (2014) Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol 15:1215\u20131223","journal-title":"Lancet Oncol"},{"key":"2608_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/oxfordjournals.aje.a009995","volume":"150","author":"AM Chiarelli","year":"1999","unstructured":"Chiarelli AM, Marrett LD, Darlington G (1999) Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964\u20131988 in Ontario, Canada. Am J Epidemiol 150:245\u2013254","journal-title":"Am J Epidemiol"},{"key":"2608_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1470-2045(13)70251-1","volume":"14","author":"SE Barton","year":"2013","unstructured":"Barton SE, Najita JS, Ginsburg ES et al (2013) Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 14:873\u2013881","journal-title":"Lancet Oncol"},{"key":"2608_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0959-8049(98)00024-0","volume":"34","author":"F Flamant","year":"1988","unstructured":"Flamant F, Rodary C, Rey A et al (1988) Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34:1050\u20131062","journal-title":"Eur J Cancer"},{"key":"2608_CR17","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1200\/JCO.1999.17.12.3706","volume":"17","author":"E Koscielniak","year":"1999","unstructured":"Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706\u20133719","journal-title":"J Clin Oncol"},{"key":"2608_CR18","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2014.55.6787","volume":"32","author":"DO Walterhouse","year":"2014","unstructured":"Walterhouse DO, Pappo AS, Meza JS et al (2014) Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children\u2019s Oncology Group. J Clin Oncol 32:3547\u20133552","journal-title":"J Clin Oncol"},{"key":"2608_CR19","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/cncr.30613","volume":"123","author":"DO Walterhouse","year":"2017","unstructured":"Walterhouse DO, Pappo AS, Meza JL et al (2017) Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: a report from the Soft Tissue Sarcoma Committee of the Children\u2019s Oncology Group. Cancer 123:2368\u20132375","journal-title":"Cancer"},{"key":"2608_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10147-006-0638-6","volume":"12","author":"H Hosoi","year":"2007","unstructured":"Hosoi H, Teramukai S, Matsumoto Y et al (2007) A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan. Int J Clin Oncol 12:137\u2013145","journal-title":"Int J Clin Oncol"},{"key":"2608_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L","volume":"76","author":"WA Newton Jr","year":"1995","unstructured":"Newton WA Jr, Gehan EA, Webber BL et al (1995) Classification of rhabdomyosarcoma and related sarcomas. Pathologic aspects and proposals for a new classification\u2014an intergroup rhabdomyosarcoma study. Cancer 76:1073\u20131085","journal-title":"Cancer"},{"key":"2608_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"2608_CR23","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.2004.08.075","volume":"22","author":"C Arndt","year":"2004","unstructured":"Arndt C, Hawkins D, Anderson JR et al (2004) Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. J Clin Oncol 22:1895\u20131901","journal-title":"J Clin Oncol"},{"key":"2608_CR24","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1200\/JCO.2010.30.4469","volume":"29","author":"RB Raney","year":"2011","unstructured":"Raney RB, Walterhouse DO, Meza JL et al (2011) Results of the intergroup rhabdomyosarcoma study group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children\u2019s Oncology Group. J Clin Oncol 29:1312\u20131318","journal-title":"J Clin Oncol"},{"key":"2608_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ijrobp.2011.06.2011","volume":"83","author":"J Breneman","year":"2012","unstructured":"Breneman J, Meza J, Donaldson SS et al (2012) Local control with reduced dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children\u2019s Oncology Group D9602 study. Int J Radiat Oncol Biol Phys 83:720\u2013726","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2608_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/pbc.24950","volume":"61","author":"H Russell","year":"2014","unstructured":"Russell H, Swint JM, Lal L et al (2014) Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 61:970\u2013976","journal-title":"Pediatr Blood Cancer"},{"key":"2608_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pbc.22928","volume":"57","author":"DO Walterhouse","year":"2011","unstructured":"Walterhouse DO, Meza JL, Breneman JC et al (2011) Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children\u2019s Oncology Group. Pediatr Blood Cancer 57:76\u201383","journal-title":"Pediatr Blood Cancer"},{"key":"2608_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018344","volume":"98","author":"M Miyachi","year":"2019","unstructured":"Miyachi M, Tsuchiya K, Hosono A et al (2019) Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: a study protocol. Medicine 98:e18344","journal-title":"Medicine"},{"key":"2608_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29924","volume":"69","author":"KD Wyatt","year":"2022","unstructured":"Wyatt KD, Birz S, Hawkins DS (2022) Creating a data commons: the international soft tissue sarcoma consortium (INSTRuCT). Pediatr Blood Cancer 69:e29924","journal-title":"Pediatr Blood Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02608-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T21:02:14Z","timestamp":1729890134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02608-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2608"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02608-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3838227\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}